Random triples
| Subject | Object |
|---|---|
| gptkb:Relating_Clinical_Outcomes_in_Multiple_Myeloma_to_Personal_Assessment_of_Genetic_Profile_Study | 2017 |
| gptkb:NCT02475681 | September 2021 |
| gptkb:SURPASS-2 | 2021 |
| gptkb:NCT02477826 | September 2022 |
| gptkb:NCT01449370 | April 2015 |
| gptkb:SURPASS-3 | 2021 |
| gptkb:NCT03581786 | 2020-01-31 |
| gptkb:NCT02366143 | October 2018 |
| gptkb:NCT03887455 | September 30, 2021 |
| gptkb:NCT04505722 | 2022-02-25 |
| gptkb:A_Study_of_Pembrolizumab_(MK-3475)_in_Combination_With_Axitinib_as_First-Line_Treatment_for_Locally_Advanced_or_Metastatic_Renal_Cell_Carcinoma_(MK-3475-426/KEYNOTE-426) | 2018-12 |
| gptkb:NCT00239681 | December 2006 |
| gptkb:NCT04374877 | August 2020 |
| gptkb:NCT01596270 | April 2015 |
| gptkb:SURPASS-4 | 2021 |
| gptkb:NCT02142738 | March 2015 |
| gptkb:NCT03013101 | October 2020 |
| gptkb:NCT02915432 | 2019-03-31 |
| gptkb:NCT05240898 | 2027-06-01 |
| gptkb:CLARITY-AD | March 2022 |